IMMUNO BIOTECH Launches Dengue IgG/IgM Rapid Test
Dual Antibody Detection in 15 Minutes with 20μL Blood Sample
2025-02-18
Dual Antibody Detection in 15 Minutes with 20μL Blood Sample
Dengue Fever and Diagnostic Significance
Dengue fever, a mosquito-borne viral disease prevalent in tropical and subtropical regions, manifests as high fever, severe muscle pain, rash, and potentially life-threatening hemorrhagic complications. Timely differentiation between IgM (indicating acute infection) and IgG (indicating past infection or secondary response) is critical for staging infection, guiding clinical management, and supporting epidemiological surveillance.
Product Overview
IMMUNO BIOTECH’s Dengue IgG/IgM Rapid Test employs advanced immunochromatographic technology to simultaneously detect both IgG and IgM antibodies from 20μL of venous or capillary whole blood. The test utilizes highly specific recombinant dengue antigens to generate distinct visual bands for each antibody type, achieving a sensitivity of 95% and specificity exceeding 98%. Results are interpretable within 15 minutes, enabling rapid decision-making across diverse healthcare settings.
Key Applications
- Clinical Diagnosis: Supports emergency departments and outpatient clinics in differentiating acute vs. convalescent dengue cases.
- Public Health Screening: Ideal for port-of-entry screening, outbreak zones, and resource-limited regions.
- Epidemiological Surveillance: Facilitates large-scale antibody prevalence studies and infection trend monitoring.
- Travel Medicine: Provides pre- or post-travel infection risk assessment for individuals visiting endemic areas.
Technical Highlights
- Dual Target Detection: Single-step workflow for concurrent IgG/IgM analysis, eliminating repeat testing.
- Environmental Robustness: Stable at ≤30°C with desiccant-protected packaging, ensuring reliability in tropical climates.
- User-Friendly Design: Streamlined three-step procedure (sample collection → application → visual interpretation) requires no instrumentation.
Availability
The Dengue IgG/IgM Rapid Test is now available for institutional procurement, including hospitals, public health agencies, and international distributors. Technical specifications and bulk order inquiries can be directed to IMMUNO BIOTECH’s global sales team.
About IMMUNO BIOTECH
A pioneer in rapid diagnostic solutions, IMMUNO BIOTECH delivers high-performance assays for infectious diseases, including dengue, malaria, and zoonotic pathogens. Our products are deployed in over 90 countries, empowering frontline healthcare providers with accessible diagnostic.
Related News